Methyl 4-Hydroxy-2-Methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-Dioxide (CAS 35511-15-0)
High-quality pharmaceutical intermediate for advanced research and development.
Get a Quote & SampleProduct Core Value
Methyl 4-Hydroxy-2-Methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-Dioxide
This compound, identified by CAS 35511-15-0, is a critical Piroxicam Impurity J, essential for pharmaceutical quality control and research.
- Sourced from a leading supplier for reliable Piroxicam Impurity J, ensuring consistency in your research.
- High purity (>99%) ensures accurate results when using this pharmaceutical intermediate in synthesis.
- White powder form facilitates easy handling and precise measurement for chemical synthesis applications.
- Fast delivery within 7-10 days supports timely project progression for critical chemical synthesis needs.
Key Advantages
Stringent Quality Control
Benefit from rigorous quality management, ensuring each batch of this CAS 35511-15-0 meets high standards for your research chemical needs.
Advanced R&D Capabilities
Leverage the supplier's R&D expertise for your custom synthesis requirements, offering tailored solutions for complex compounds.
Global Supply Chain Integration
Access a stable supply of this essential pharmaceutical intermediate, backed by a company with extensive experience in the global market.
Key Applications
Pharmaceutical Research
Utilize Methyl 4-Hydroxy-2-Methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-Dioxide as a key reference standard or intermediate in drug discovery and development.
Quality Assurance
Employ this compound for quality control testing, ensuring the purity and efficacy of pharmaceutical products, crucial for Piroxicam Impurity J analysis.
Chemical Synthesis
Integrate this fine chemical into complex organic synthesis pathways, leveraging its specific molecular structure for novel compound creation.
Analytical Method Development
Develop and validate analytical methods using this high-purity standard, vital for impurity identification and quantification in pharmaceutical manufacturing.